Manufacturer: Torrent Pharma
Pharmaceutical name: Repaglinide
Pack: 10 pills (1 mg)
Eurepa is utilized for managing type 2 diabetes, a condition where the body fails to properly use insulin, leading to difficulties in controlling blood sugar levels. This medication aids in regulating blood glucose by prompting the pancreas to produce insulin.
Eurepa falls under the meglitinides category of medications. It is taken orally, alongside a physician-recommended diet, exercise, and significant lifestyle modifications to maximize its effectiveness. It is crucial to avoid smoking and limit alcohol consumption during and after the treatment phase. Additionally, managing stress is vital as it can significantly impact blood sugar levels. Eurepa is prescribed to regulate blood sugar levels in individuals with Type 2 Diabetes mellitus. By stimulating insulin production, it helps lower and normalize glucose levels in the body. Furthermore, this medication can reduce the risk of kidney failure and cardiovascular issues. However, Eurepa is not suitable for patients with Type 1 Diabetes or diabetic ketoacidosis, nor is it advised for those who are allergic or hypersensitive to any of its components.
There may be some potential side effects associated with this medication. If symptoms persist or discomfort intensifies, it is important to seek medical advice promptly. Common side effects include blurred vision, vomiting, diarrhea, headaches, respiratory infections, sinusitis, rhinitis, constipation, and pain and swelling in muscles or joints.